A. Sabbah

发表

A retrospective analysis of dental implant survival in HIV patients

Wayne S Gardner, J. Gelfond, Qianqian Liu, 2019, Journal of clinical periodontology.

Anti-cancer oncolytic activity of respiratory syncytial virus

B. Chatterjee, I. Echchgadda, S. Bose, 2009, Cancer Gene Therapy.

ROLE OF HUMAN BETA DEFENSIN-2 DURING TUMOR NECROSIS FACTOR- α /NF- κ B MEDIATED INNATE ANTI-VIRAL RESPONSE AGAINST HUMAN RESPIRATORY SYNCYTIAL VIRUS

Y. Xiang, Xiangzhi Meng, T. Chang, 2008 .

Corrigendum: Activation of innate immune antiviral responses by Nod2

K. Tominaga, Y. Xiang, Victoria Frohlich, 2010, Nature Immunology.

Activation of innate immune antiviral response by NOD2

Kaoru Tominaga, Santanu Bose, Yan Xiang, 2009, Nature Immunology.

TLR2/MyD88/NF-κB Pathway, Reactive Oxygen Species, Potassium Efflux Activates NLRP3/ASC Inflammasome during Respiratory Syncytial Virus Infection

Santanu Bose, Irving C. Allen, J. Ting, 2012, PloS one.

Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

Y. Ikeno, G. Hubbard, B. Chatterjee, 2011, BMC Cancer.

Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus*

Y. Xiang, Xiangzhi Meng, T. Chang, 2008, Journal of Biological Chemistry.

Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles.

J. Segovia, T. Chang, S. Bose, 2012, Virology.

Retinoic acid inducible gene I Activates innate antiviral response against human parainfluenza virus type 3

S. Bose, A. Sabbah, 2009, Virology Journal.

Anticancer oncolytic activity of respiratory syncytial virus

B. Chatterjee, I. Echchgadda, S. Bose, 2009, Cancer Gene Therapy.

Retinoic acid inducible gene I Activates innate antiviral response against human parainfluenza virus type 3

S. Bose, A. Sabbah, 2009, Virology Journal.